Filing Details
- Accession Number:
- 0001140361-14-011987
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-10 18:16:15
- Reporting Period:
- 2014-03-06
- Filing Date:
- 2014-03-10
- Accepted Time:
- 2014-03-10 18:16:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557533 | Robert Jeffrey Ajer | C/O Biomarin Pharmaceutical Inc., 105 Digital Drive Novato CA 94949 | Svp, Chief Commercial Of | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-03-06 | 2,558 | $21.51 | 27,938 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-03-06 | 14,812 | $28.23 | 42,750 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-03-06 | 17,370 | $78.63 | 25,380 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock | Disposition | 2014-03-06 | 2,558 | $0.00 | 2,558 | $21.51 |
| Common Stock | Common Stock | Disposition | 2014-03-06 | 14,812 | $0.00 | 14,812 | $28.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,125 | 2010-11-12 | 2020-05-11 | No | 4 | M | Direct |
| 5,258 | 2011-12-01 | 2021-05-30 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 plan executed on December 12, 2013.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $77.48 to $79.59. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- Original option grant vests 6/48th on November 12, 2010 and 1/48th on the 12th of each month thereafter.
- Original option grant vests 6/48th on December 1, 2011 and 1/48th on the 1st of each month thereafter.
- Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.
Billionaire Hedge Funds
